JP2024531685A5 - - Google Patents
Info
- Publication number
- JP2024531685A5 JP2024531685A5 JP2024515840A JP2024515840A JP2024531685A5 JP 2024531685 A5 JP2024531685 A5 JP 2024531685A5 JP 2024515840 A JP2024515840 A JP 2024515840A JP 2024515840 A JP2024515840 A JP 2024515840A JP 2024531685 A5 JP2024531685 A5 JP 2024531685A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic composition
- apomorphine
- tgf
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163243175P | 2021-09-12 | 2021-09-12 | |
| US202163243177P | 2021-09-12 | 2021-09-12 | |
| US63/243,177 | 2021-09-12 | ||
| US63/243,175 | 2021-09-12 | ||
| PCT/US2022/075763 WO2023039345A2 (en) | 2021-09-12 | 2022-08-31 | Treatment of neurological disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531685A JP2024531685A (ja) | 2024-08-29 |
| JP2024531685A5 true JP2024531685A5 (cg-RX-API-DMAC10.html) | 2025-09-08 |
Family
ID=85506869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515840A Pending JP2024531685A (ja) | 2021-09-12 | 2022-08-31 | 神経障害の処置 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240216359A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4398908A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024531685A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240069750A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022341090B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3231407A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024002875A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023039345A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4720299A1 (en) * | 2023-06-05 | 2026-04-08 | GMP Biotechnology Limited | Tgfb2-irf5 therapeutics for cancer |
| WO2025071299A1 (ko) * | 2023-09-27 | 2025-04-03 | 아주대학교산학협력단 | C-fos 억제제의 우울/불안 장애를 동반한 파킨슨병 치료 용도 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69434304T2 (de) * | 1993-03-26 | 2005-12-29 | Merkus, Franciscus Wilhelmus H.M. | Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin |
| US6436950B1 (en) * | 1998-08-14 | 2002-08-20 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of apomorphine |
| CN1989244B (zh) * | 2004-02-09 | 2013-04-03 | 柏格丹由里 | 用于治疗cns病症的tgf-r信号传递抑制剂 |
| EP2854764B1 (en) * | 2012-06-05 | 2018-12-12 | Neuroderm Ltd | Compositions comprising apomorphine and organic acids and uses thereof |
| MA43042A (fr) * | 2015-09-28 | 2018-08-08 | Ever Neuro Pharma Gmbh | Composition aqueuse d'apomorphine pour une administration sous-cutanée |
| US9758786B2 (en) * | 2016-02-09 | 2017-09-12 | Autotelic, Llc | Compositions and methods for treating pancreatic cancer |
| CN115968285A (zh) * | 2020-03-18 | 2023-04-14 | Gmp生物技术有限公司 | TGF-β抑制、用于其的药剂及组合物 |
| AU2021102241A4 (en) * | 2021-04-29 | 2021-06-17 | University Of Macau | Application of Artemisinin Compounds in Preparation of Drug for Preventing and Treating Brain Diseases |
-
2022
- 2022-08-31 KR KR1020247012048A patent/KR20240069750A/ko active Pending
- 2022-08-31 JP JP2024515840A patent/JP2024531685A/ja active Pending
- 2022-08-31 MX MX2024002875A patent/MX2024002875A/es unknown
- 2022-08-31 WO PCT/US2022/075763 patent/WO2023039345A2/en not_active Ceased
- 2022-08-31 CA CA3231407A patent/CA3231407A1/en active Pending
- 2022-08-31 AU AU2022341090A patent/AU2022341090B2/en active Active
- 2022-08-31 EP EP22868224.1A patent/EP4398908A4/en active Pending
-
2024
- 2024-03-11 US US18/600,993 patent/US20240216359A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016371598B2 (en) | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | |
| US9107925B2 (en) | Sodium channel blocker for treatment of loss of superficial sensitivity | |
| EP4114466B1 (en) | Treatment of pain and vasoconstriction | |
| JP7107624B2 (ja) | エダラボンの経口又は胃内投与を含む処置 | |
| KR20180100309A (ko) | 데옥시콜산 및 이의 염을 사용한 축적된 지방의 치료 방법 | |
| US20240216359A1 (en) | Treatment of neurological disorders | |
| WO2020053665A2 (en) | Non-aqueous chemotherapeutic suspensions for oral dosage | |
| US20160082026A1 (en) | Ganglioside Transmucosal Formulations | |
| KR20180066071A (ko) | 비점막 투여용 의약 조성물 | |
| JP2011144111A (ja) | 軸性近視の予防または治療剤 | |
| CN110461325A (zh) | 包括口服或胃部施用依达拉奉的治疗 | |
| CN116942618B (zh) | 一种适用于耳鼓给药的地塞米松磷酸钠冻干组合物及其制备方法 | |
| CA3149980A1 (en) | Therapeutic methods and uses thereof | |
| EP4420660A1 (en) | Use of edaravone in treatment of autism spectrum disorder | |
| CN112516091B (zh) | 一种地塞米松磷酸钠冻干粉针剂 | |
| JP2018108993A (ja) | 注腸剤 | |
| CN118252833A (zh) | Vofopitant用于治疗肺纤维化的用途 | |
| CN113950331A (zh) | 用于改善泌乳的美洛缩宫素的鼻内施用 | |
| EP3215125B1 (en) | Compositions comprising finafloxacin and tris | |
| US11858908B2 (en) | Compositions and methods for inhibiting IDO1 | |
| US20230031188A1 (en) | Methods of Treating Skin Diseases | |
| KR20240025512A (ko) | 건선의 치료 방법 | |
| HK40113386A (zh) | 神经病症的治疗 | |
| CA2554045A1 (en) | Method for treating erectile dysfunction | |
| JPH0892089A (ja) | ドライバジャイナ治療剤 |